Inferior vena cava thrombectomy following complete response to nivolumab/ipilimumab for metastatic renal cell carcinoma

ANZ J Surg. 2020 Jul;90(7-8):1517-1519. doi: 10.1111/ans.15608. Epub 2019 Dec 12.

Authors

Andrew R H Shepherd^{1

2}, Rohit Joshi^{2

3}, Chuan Ping Tan⁴, Penelope Cohen⁵, Nicholas R Brook^{1

2}

Affiliations

¹ Department of Urology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
² Adelaide Medical School, The University of Adelaide, Adelaide, South Australia, Australia.
³ Department of Medical Oncology, Lyell McEwin Hospital, Adelaide, South Australia, Australia.
⁴ Department of Surgery, Royal Adelaide Hospital, Adelaide, South Australia, Australia.
⁵ SA Pathology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.

PMID: 31833177
DOI: 10.1111/ans.15608

No abstract available

MeSH terms

Carcinoma, Renal Cell* / drug therapy
Carcinoma, Renal Cell* / surgery
Humans
Ipilimumab
Kidney Neoplasms* / drug therapy
Kidney Neoplasms* / surgery
Nephrectomy
Nivolumab / therapeutic use
Thrombectomy
Vena Cava, Inferior / diagnostic imaging
Vena Cava, Inferior / surgery

Substances

Ipilimumab
Nivolumab